Antibodies elicited by infection accumulate somatic mutations in germinal centers that can
increase affinity for cognate antigens. We analyzed 6 independent groups of clonally related …

Infection with SARS‐CoV‐2 elicits robust antibody responses in some patients, with a
majority of the response directed at the receptor binding domain (RBD) of the spike surface …

Seven coronaviruses are known to cause infection/disease in humans. Of these, human
coronavirus (HCoV)-229E and HCoV-NL63 are alphacoronaviruses (α-CoVs), whereas …

Several potent neutralizing antibodies against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus have been identified. However, antibody-dependent …

The Omicron variant of SARS-CoV-2 has been shown to evade neutralizing antibodies
elicited by vaccination or infection. Despite the global spread of the Omicron variant, even …

Summary Many SARS-CoV-2-infected individuals remain asymptomatic. Little is known
about the extent and quality of their antiviral humoral response. Here, we analyze antibody …

The pandemic of COVID-19 caused by SARS-CoV-2 continues to spread around the world.
Mutant strains of SARS-CoV-2 are constantly emerging. At present, Omicron variants have …

To combat the COVID-19 pandemic, potential therapies have been developed and moved
into clinical trials at an unprecedented pace. Some of the most promising therapies are …

Many potent neutralizing SARS-CoV-2 antibodies have been developed and used for
therapies. However, the effectiveness of many antibodies has been reduced against recently …

SARS-CoV-2 rapidly evolves during the pandemic 1 with many variants of concern (VoCs)
lineages (Supplementary Fig. S1a). Omicron (B. 1.1. 529) and its sub-lineages led to …